Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given “Buy” Rating at TD Cowen

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)‘s stock had its “buy” rating reaffirmed by stock analysts at TD Cowen in a report released on Tuesday, Benzinga reports. They presently have a $15.00 price objective on the stock. TD Cowen‘s price objective would suggest a potential upside of 93.55% from the company’s current price.

A number of other brokerages have also issued reports on SENS. Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 8th. Mizuho reduced their price target on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, July 15th. Barclays started coverage on shares of Senseonics Holdings, Inc. Common Stock in a report on Wednesday, October 7th. They issued an “equal weight” rating and a $10.00 price target on the stock. Finally, Weiss Ratings downgraded shares of Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $13.00.

Senseonics Holdings, Inc. Common Stock Stock Performance

NASDAQ SENS traded up $0.27 during trading on Tuesday, reaching $7.75. The company’s stock had a trading volume of 210,794 shares, compared to its average volume of 661,546. The company has a debt-to-equity ratio of 0.62, a quick ratio of 6.40 and a current ratio of 6.74. The firm has a market cap of $323.95 million, a price-to-earnings ratio of -3.44 and a beta of 1.02. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $10.64. The business’s fifty day moving average price is $9.15 and its 200-day moving average price is $7.16.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.63) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The business had revenue of $14.48 million during the quarter. As a group, analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.31 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Douglas Roeder purchased 13,953 shares of the business’s stock in a transaction on Wednesday, August 19th. The shares were bought at an average price of $8.98 per share, with a total value of $125,297.94. Following the completion of the purchase, the director directly owned 171,191 shares in the company, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. 4.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

A number of large investors have recently bought and sold shares of SENS. Integrated Wealth Concepts LLC purchased a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth approximately $36,000. The Manufacturers Life Insurance Company purchased a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth approximately $65,000. State of Wyoming purchased a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth approximately $67,000. Kestra Advisory Services LLC purchased a new position in Senseonics Holdings, Inc. Common Stock during the first quarter worth approximately $68,000. Finally, Cetera Investment Advisers purchased a new position in Senseonics Holdings, Inc. Common Stock during the first quarter worth approximately $85,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.